## Abbott Hit with $53 Million Jury Verdict in Chicago Preterm Infant Formula Case
A Chicago jury has delivered a significant legal blow to Abbott Laboratories, ordering the healthcare giant to pay $53 million in a trial concerning its preterm infant formula. The verdict represents a major financial liability and a public relations setback for Abbott, centering on allegations related to the safety and marketing of its specialized nutritional products for vulnerable newborns.

The case, heard in a Cook County court, stems from claims brought by the family of a premature infant. The jury's decision to award substantial compensatory damages directly ties Abbott's product to alleged harm, placing the company's infant nutrition division under intense legal and public scrutiny. This trial is distinct from the broader Similac recall linked to a Michigan plant, focusing instead on specific product liability claims in the preterm infant market, a critical and sensitive segment of Abbott's business.

The $53 million judgment signals mounting legal pressure on formula manufacturers and could prompt further lawsuits from other families. While Abbott is expected to appeal, the verdict immediately impacts its financial reserves and corporate reputation. It also raises broader questions about regulatory oversight and corporate responsibility within the lucrative but high-stakes infant formula industry, where product safety failures carry profound consequences.
---
- **Source**: Seeking Alpha
- **Sector**: The Lab
- **Tags**: product liability, infant formula, jury verdict, healthcare litigation, Chicago
- **Credibility**: unverified
- **Published**: 2026-04-10 08:39:29
- **ID**: 58393
- **URL**: https://whisperx.ai/en/intel/58393